Global antibody development trends

mAbs

Volumn 1, Issue 1, 2009, Pages 86-87

  Reichert, Janice M ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Antibody; Clinical study; Development trends

Indexed keywords

ADALIMUMAB; BEVACIZUMAB; CETUXIMAB; GOLIMUMAB; INFLIXIMAB; MONOCLONAL ANTIBODY; PALIVIZUMAB; RANIBIZUMAB; RITUXIMAB; TRASTUZUMAB; USTEKINUMAB;

BIOTECHNOLOGY; DRUG APPROVAL; DRUG EFFICACY; DRUG INDUSTRY; DRUG MARKETING; DRUG QUALITY; DRUG RESEARCH; DRUG SAFETY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HUMAN; NONHUMAN;

ANIMALS; ANTIBODIES, MONOCLONAL; DRUG INDUSTRY; HUMANS; MICE;

EID: 72449187333     PISSN: 19420862     EISSN: None     Source Type: Journal    
DOI: 10.4161/mabs.1.1.7645     Document Type: Editorial

References (0)